JAMA News
Most Popular JAMA Story
Flu shots, Relenza to benefit from Tamiflu trouble
In the medical journal equivalent of a newspaper Extra! edition, the Journal of the American Medical Association went to press early with several stories on this year's flu resistance to Roche's Read more...
Latest Headlines
- September 2, 2010
- September 11, 2009
- March 3, 2009
- December 3, 2008
- November 19, 2008
- October 8, 2008
- May 21, 2008
- April 23, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
